A Prospective Observational Study of qSOFA Score Combined With Initial Red Cell Distribution Width as a Diagnostic Indicator of 30 Days Mortality in Patients With Infection at Emergency Department
Main Article Content
Abstract
Introduction:
Sepsis is a major cause of morbidity and mortality in emergency settings. Quick Sequential Organ Failure Assessment (qSOFA) is a bedside tool used to identify high-risk patients. Red cell distribution width (RDW), a routinely available haematological parameter, has been linked to adverse outcomes in various critical conditions. This study explores the association between qSOFA combined with RDW and 30-day mortality in infected patients presenting to the emergency department.
Methods:
A prospective observational study was conducted from 2023 to 2024 in the Emergency Department of Rajiv Gandhi Government General Hospital, Chennai. A total of 100 adult patients with suspected infection or sepsis were enrolled. Patients with nutritional anaemia, red blood cell disorders, immune compromised states, or terminal malignancy were excluded. Vital signs and Glasgow Coma Scale were recorded t calculate qSOFA. RDW was stratified into three groups: 12–14%, 14–14.9%, and ≥15%. Patients were followed for 30 days, and outcomes were categorized as discharged or expired. Statistical analysis including chi-square, t-tests, sensitivity/specificity, and ROC curves was performed using SPSS.
Results:
Among 100 patients, 82% expired, and 18% were discharged. Higher qSOFA scores (score 3: 91% mortality) and elevated RDW (>15%: 93.3% mortality) were significantly associated with poor outcomes. The combinationof qSOFA ≥2 and RDW >15% showed the highest predictive value for mortality (97% mortality, p<0.05). ROC curve analysis yielded an AUC of 0.52 for the combined score, indicating limited but suggestive predictive value.
Conclusion:
qSOFA score combined with RDW is significantly associated with 30-day mortality in patients presenting with infection. While RDW alone had moderate predictive strength, its integration with qSOFA enhanced mortality prediction. Given its availability and cost-effectiveness, RDW may serve as a valuable adjunct in early sepsis risk stratification.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
References
1. La Via L, Sangiorgio G, Stefani S, et al. The Global Burden of Sepsis and Septic Shock. Epidemiologia. 2024;5(3):456-478. doi:https://doi.org/10.3390/epidemiologia5030032
2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and National Sepsis Incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. The Lancet. 2020;395(10219):200-211. doi:https://doi.org/10.1016/S0140-6736(19)32989-7
3. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock. JAMA. 2016;315(8):775. doi:https://doi.org/10.1001/jama.2016.0289
4. Mehta S, Gill SE. Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine. Journal of Thoracic Disease. 2019;11(1):21-28. doi:https://doi.org/10.21037/jtd.2018.11.74
5. Li L, Rathnayake K, Green M, et al. Improving the Performance of Clinical Decision Support for Early Detection of Sepsis: A Retrospective Observational Cohort Study. Studies in Health Technology and Informatics. 2019;264:679-683. doi:https://doi.org/10.3233/SHTI190309
6. Moreno-Torres V, Royuela A, Múñez-Rubio E, et al. Red blood cell distribution width as prognostic factor in sepsis: A new use for a classical parameter. Journal of Critical Care. 2022;71:154069. doi:https://doi.org/10.1016/j.jcrc.2022.154069
7. Weiss G, Ganz T, Goodnough LT. Anemia of Inflammation. Blood. 2019;133(1):40-50. doi:https://doi.org/10.1182/blood-2018-06-856500
8. Beltrán-García J, Osca-Verdegal R, Romá-Mateo C, et al. Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression. Epigenomics. 2020;12(7):617-646. doi:https://doi.org/10.2217/epi-2019-0329
9. Nunnally ME, Ferrer R, Martin GS, et al. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Medicine Experimental. 2021;9(1). doi:https://doi.org/10.1186/s40635-021-00400-z
10. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis. JAMA. 2016;315(8):762. doi:https://doi.org/10.1001/jama.2016.0288
11. Kim SY, Woo SH, Lee WJ, et al. The qSOFA score combined with the initial red cell distribution width as a useful predictor of 30 day mortality among older adults with infection in an emergency department. Aging Clinical and Experimental Research. 2020;33(6):1619-1625. doi:https://doi.org/10.1007/s40520-020-01738-2
12. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Critical Care Medicine. 2017;45(3):486-552. doi:https://doi.org/10.1097/ccm.0000000000002255
13. Spiegel R, Farkas JD, Rola P, et al. The 2018 Surviving Sepsis Campaign’s Treatment Bundle: When Guidelines Outpace the Evidence Supporting Their Use. Annals of Emergency Medicine. 2019;73(4):356-358. doi:https://doi.org/10.1016/j.annemergmed.2018.06.046
14. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Critical Care Medicine. 1998;26(12):2078-2086. doi:https://doi.org/10.1097/00003246-199812000-00045
15. Novosad SA, Sapiano MRP, Grigg C, et al. Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention. MMWR Morbidity and Mortality Weekly Report. 2016;65(33):864-869. doi:https://doi.org/10.15585/mmwr.mm6533e1
16. Safabakhsh M, Imani H, Shahinfar H, Mohammadpour M, Rohani P, Shab-Bidar S. Efficacy of dietary supplements on mortality and clinical outcomes in adults with sepsis and septic shock: A systematic review and network meta-analysis. Clinical Nutrition. 2024;43(6):1299-1307. doi:https://doi.org/10.1016/j.clnu.2024.03.030
17. Cao XR, Xu YL, Chai JW, et al. Pretreatment red blood cell distribution width as a predictive marker for postoperative complications after laparoscopic pancreatoduodenectomy. World journal of gastrointestinal oncology. 2025;17(1):98168. doi:https://doi.org/10.4251/wjgo.v17.i1.98168
18. Dantes RB, Epstein L. Combatting Sepsis: A Public Health Perspective. Clinical Infectious Diseases. 2018;67(8):1300-1302. doi:https://doi.org/10.1093/cid/ciy342
19. Rhee C, Dantes R, Epstein L, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017;318(13):1241. doi:https://doi.org/10.1001/jama.2017.13836
20. Rivers EP, Katranji M, Jaehne KA, et al. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiologica. 2012;78(6):712-724. https://pubmed.ncbi.nlm.nih.gov/22447123/